(Q38003847)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22517031%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22517031%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22517031%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Nobutaka Fujii

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22517031%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

19 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22517031%20AND%20SRC:MED&resulttype=core&format=json

Organic and Biomolecular Chemistry

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22517031%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22517031%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22517031%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

5720-5731

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22517031%20AND%20SRC:MED&resulttype=core&format=json

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

CXCL12 and CXCR4 in bone marrow physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Homeostatic chemokine receptors and organ-specific metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

CXCR4 receptor as a promising target for oncolytic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Potential of CXCR4 antagonists for the treatment of metastatic lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Plerixafor: in patients with non-Hodgkin's lymphoma or multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil™) and potential of other CXCR4 antagonists as stem cell mobilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Plerixafor: a review of its use in stem-cell mobilization in patients with lymphoma or multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

The chemokine receptor CXCR4 as a therapeutic target for several diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Therapeutic potential of the chemokine receptor CXCR4 antagonists as multifunctional agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Development of low molecular weight CXCR4 antagonists by exploratory structural tuning of cyclic tetra- and pentapeptide-scaffolds towards the treatment of HIV infection, cancer metastasis and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Small molecule CXCR4 chemokine receptor antagonists: developing drug candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Small molecules anti-HIV therapeutics targeting CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Recent patents regarding the discovery of small molecule CXCR4 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

The CXCL12/CXCR4 axis as a therapeutic target in cancer and HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Small molecule HIV entry inhibitors: Part I. Chemokine receptor antagonists: 2004 - 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

CXCR4-based imaging agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Inhibitory effect of tachyplesin I on the proliferation of human immunodeficiency virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II: chemical structures and biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

A comparative study of the solution structures of tachyplesin I and a novel anti-HIV synthetic peptide, T22 ([Tyr5,12, Lys7]-polyphemusin II), determined by nuclear magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Molecular parameters for the anti-human immunodeficiency virus activity of T22 ([Tyr5,12, Lys7]-polyphemusin II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Structure-activity relationships of an anti-HIV peptide, T22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Pharmacophore identification of a chemokine receptor (CXCR4) antagonist, T22 ([Tyr(5,12),Lys7]-polyphemusin II), which specifically blocks T cell-line-tropic HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

An anti-HIV peptide, T22, forms a highly active complex with Zn(II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Lymphocytes and promonocytes attach to the synthetic [Tyr5,12, Lys7]- polyphemusin II peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

The synthetic [Tyr5,12,Lys7]-polyphemusin II peptide (T22) binds to the CD4 cell surface molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Interaction of an anti-HIV peptide, T22, with gp120 and CD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Analysis of the interaction of an anti-HIV peptide, T22 ([Tyr5, 12, Lys7]-polyphemusin II), with gp120 and CD4 by surface plasmon resonance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Effective lowly cytotoxic analogs of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Certification of the critical importance of L-3-(2-naphthyl)alanine at position 3 of a specific CXCR4 inhibitor, T140, leads to an exploratory performance of its downsizing study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Increase of R5 HIV-1 infection and CCR5 expression in T cells treated with high concentrations of CXCR4 antagonists and SDF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Marked increase in anti-HIV activity, as well as inhibitory activity against HIV entry mediated by CXCR4, linked to enhancement of the binding ability of tachyplesin analogs to CXCR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads to development of effective anti-HIV agents with very high selectivity indexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Conformational study of a highly specific CXCR4 inhibitor, T140, disclosing the close proximity of its intrinsic pharmacophores associated with strong anti-HIV activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Synthesis and evaluation of pseudopeptide analogues of a specific CXCR4 inhibitor, T140: the insertion of an (E)-alkene dipeptide isostere into the betaII'-turn moiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Synthesis of potent CXCR4 inhibitors possessing low cytotoxicity and improved biostability based on T140 derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

HIF-1: an oxygen and metal responsive transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Identification of a CXCR4 antagonist, a T140 analog, as an anti-rheumatoid arthritis agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

The CXCR4 antagonist 4F-benzoyl-TN14003 stimulates the recovery of the bone marrow after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Synthesis and evaluation of bifunctional anti-HIV agents based on specific CXCR4 antagonists-AZT conjugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Lipid bilayer simulations of CXCR4 with inverse agonists and weak partial agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Photolabeling identifies transmembrane domain 4 of CXCR4 as a T140 binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Mapping the ligand-binding site on a G protein-coupled receptor (GPCR) using genetically encoded photocrosslinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Molecular-size reduction of a potent CXCR4-chemokine antagonist using orthogonal combination of conformation- and sequence-based libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Topochemical exploration of potent compounds using retro-enantiomer libraries of cyclic pentapeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Structure-activity relationship studies on CXCR4 antagonists having cyclic pentapeptide scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Structure-activity relationship study of CXCR4 antagonists bearing the cyclic pentapeptide scaffold: identification of the new pharmacophore

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Structure-activity relationship study on artificial CXCR4 ligands possessing the cyclic pentapeptide scaffold: the exploration of amino acid residues of pentapeptides by substitutions of several aromatic amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

The cyclic pentapeptide d-Arg3FC131, a CXCR4 antagonist, induces apoptosis of somatotrope tumor and inhibits tumor growth in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Design and synthesis of all diastereomers of cyclic pseudo-dipeptides as mimics of cyclic CXCR4 pentapeptide antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Stereoselective synthesis of [L-Arg-L/D-3-(2-naphthyl)alanine]-type (E)-alkene dipeptide isosteres and its application to the synthesis and biological evaluation of pseudopeptide analogues of the CXCR4 antagonist FC131.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Synthesis and biological evaluation of selective CXCR4 antagonists containing alkene dipeptide isosteres

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Potent CXCR4 antagonists containing amidine type Peptide bond isosteres

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Design, synthesis, and functionalization of dimeric peptides targeting chemokine receptor CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Insight into the binding mode for cyclopentapeptide antagonists of the CXCR4 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Computational analysis of the structural mechanism of inhibition of chemokine receptor CXCR4 by small molecule antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Molecular modeling study of cyclic pentapeptide CXCR4 antagonists: new insight into CXCR4-FC131 interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Discovery of novel, highly potent and selective beta-hairpin mimetic CXCR4 inhibitors with excellent anti-HIV activity and pharmacokinetic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Using a beta-hairpin to mimic an alpha-helix: cyclic peptidomimetic inhibitors of the p53-HDM2 protein-protein interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Beta-hairpin peptidomimetics: design, structures and biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Anti-HIV activity and resistance profile of the CXC chemokine receptor 4 antagonist POL3026.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1alpha, a potent ligand for the HIV-1 "fusin" coreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

A novel CXCR4 antagonist derived from human SDF-1beta enhances angiogenesis in ischaemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Identification of allosteric peptide agonists of CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

The role of positively charged residues in CXCR4 recognition probed with synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

C-terminal cyclization of an SDF-1 small peptide analogue dramatically increases receptor affinity and activation of the CXCR4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Small peptide analogs to stromal derived factor-1 enhance chemotactic migration of human and mouse hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

The many facets of SDF-1alpha, CXCR4 agonists and antagonists on hematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

A novel peptide antagonist of CXCR4 derived from the N-terminus of viral chemokine vMIP-II

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Structure-function study and anti-HIV activity of synthetic peptide analogues derived from viral chemokine vMIP-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Structure/function of human herpesvirus-8 MIP-II (1-71) and the antagonist N-terminal segment (1-10)

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Exploring the stereochemistry of CXCR4-peptide recognition and inhibiting HIV-1 entry with D-peptides derived from chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Different stereochemical requirements for CXCR4 binding and signaling functions as revealed by an anti-HIV, D-amino acid-containing SMM-chemokine ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Direct interaction between an allosteric agonist pepducin and the chemokine receptor CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Binding of ALX40-4C to APJ, a CNS-based receptor, inhibits its utilization as a co-receptor by HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Identification of a D-amino acid decapeptide HIV-1 entry inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Cutting edge: human beta defensin 3--a novel antagonist of the HIV-1 coreceptor CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Concise site-specific synthesis of DTPA-peptide conjugates: application to imaging probes for the chemokine receptor CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Synthesis and evaluation of a bimodal CXCR4 antagonistic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Hybrid peptide dendrimers for imaging of chemokine receptor 4 (CXCR4) expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Simplified syntheses of complex multifunctional nanomaterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

PET imaging of CXCR4 using copper-64 labeled peptide antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Improvement of CXCR4 tracer specificity for PET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

PET of tumor CXCR4 expression with 4-18F-T140.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

PET imaging of CXCR4 receptors in cancer by a new optimized ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Synthesis and application of fluorescein- and biotin-labeled molecular probes for the chemokine receptor CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Fluorescent imaging of high-grade bladder cancer using a specific antagonist for chemokine receptor CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Fluorophore labeling enables imaging and evaluation of specific CXCR4-ligand interaction at the cell membrane for fluorescence-based screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Immunohistochemical detection of the CXCR4 expression in tumor tissue using the fluorescent peptide antagonist Ac-TZ14011-FITC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Peptide-functionalized luminescent iridium complexes for lifetime imaging of CXCR4 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Stereoselective Synthesis of 3,6-Disubstituted-3,6-dihydropyridin-2-ones as Potential Diketopiperazine Mimetics Using Organocopper-Mediatedanti-SN2‘ Reactions and Their Use in the Preparation of Low-Molecule CXCR4 Antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Diastereoselective synthesis of highly functionalized fluoroalkene dipeptide isosteres and its application to Fmoc-based solid-phase synthesis of a cyclic pentapeptide mimetic

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

Structure–Activity Relationship Study of a CXC Chemokine Receptor Type 4 Antagonist, FC131, Using a Series of Alkene Dipeptide Isosteres

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB25107H

21 January 2018

Identifiers

DOI

10.1039/C2OB25107H

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22517031%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference